Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLT vs. Bimatoprost for Glaucoma in Africa
NCT02774811Terminated
- Sponsor
- University College London
- Start
- Feb 2014
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of bimatoprost in primary open-angle glaucoma (POAG), sponsored by University College London. Primary endpoint: Intraocular pressure reduction at 1 year. Started Feb 2014; status: terminated.
02
Drugs
bimatoprost
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT02774811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02774811.